在指纹中确定卡巴马西平:一项可行性研究,以评估患者的坚持性
Isadora Ritter Müller1,2, Valéria Tessaro Grandi3, Sarah Gondim Santos Paulino3
1Analytical Toxicology Laboratory, Universidade Feevale, Rua Rubem Berta, 200, Novo Hamburgo, RS, CEP, 93525-080, Brazil.
Bioanalysis
|March 18, 2024
概括
指纹分析提供了一种新的,非侵入性的方法来评估药物坚持. 这项研究表明,指纹卡巴马西平 (CBZ) 水平可以识别治疗效果不佳的患者.
科学领域:
- 分析化学 分析化学
- 药理学 药理学是指药理学的学科.
- 生物医学科学 生物医学科学
背景情况:
- 指纹药物度提供了一种非侵入性方法来评估药物治疗的坚持性.
- 传统的守监测方法可能对患者来说是侵入性的或不方便的.
研究的目的:
- 开发和验证一种用指纹量化碳胺 (CBZ) 的方法.
- 评估使用指纹CBZ水平来识别药物坚持低的患者的可行性.
主要方法:
- 用超高性能液体染色学-并联质谱法 (UHPLC-MS/MS) 收集,提取和分析指纹.
- 测试被验证为线性,精度和准确性.
- 分析了30名患者的指纹样本,并与坚持性问卷进行了比较.
主要成果:
- 在UHPLC-MS/MS测定证明了良好的线性 (0.05-10 ng/指纹),精度 (2.16-7.9%) 和准确性 (95.0-102.8%).
- 指纹中的碳氨酸 (CBZ) 含量在45°C稳定15天.
- 在依从度低和中/高的组之间观察到指纹CBZ度的显著差异 (p=0.003).
结论:
- 指纹分析是一种可行的,非侵入性的技术,用于监测患者的卡巴马西平坚持.
- 这种方法显示出有可能识别不遵守CBZ药物治疗的患者.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
292
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
292
Antiepileptic Drugs: Potassium Channel Activators
181
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
181
Antiepileptic Drugs: GABAergic Pathway Potentiators
396
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
396
Arteries of the Lower Limbs
188
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
188
Antiepileptic Drugs: Sodium Channel Blockers
539
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
539
Antiepileptic Drugs: Calcium Channel Blockers
387
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
387


